newsfilter
← Latest News
GlobeNewswire·

Eagle Pharmaceuticals Reports First Quarter 2023 Results

Total revenue for Q1 2023 was $66.3 million, compared to $115.9 million in Q1 2022Q1 2023 net income was $0.44 per basic and diluted share and adjusted non-GAAP net income1 was $1.27 per basic and $1.26 per diluted